Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03378245 · ClinicalTrials.gov registry record · NA
Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations
A NA study of Dementia Alzheimers and Disruptive Behavior, sponsored by Richard Ronan Murphy.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT03378245: Completed NA study of Dementia Alzheimers and Disruptive Behavior, sponsored by Richard Ronan Murphy.
NCT03378245 is a NA study of Dementia Alzheimers and Disruptive Behavior that has completed, run by Richard Ronan Murphy. The registered enrollment target is 16 participants, below the 194-participant average among 11 other Dementia Alzheimers trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03378245, a NA study of Dementia Alzheimers and Disruptive Behavior, has completed, sponsored by Richard Ronan Murphy.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the use of telemedicine-based intervention at urban and rural skilled nursing facilities to recommend multidisciplinary dementia care to residents with dementia who are at risk for unnecessary hospitalization due behavioral or neuropsychiatric symptoms and/or complications as well as caregivers and facility staff. The multidisciplinary team is comprised of trained behavioral neurologists, social workers, advanced practice providers, primary medical team and nurse coordinators.
Primary Outcome
The NPI assesses 10 behavioral symptom domains, scoring is based on symptom frequency and severity. The total NPI score sums the products of frequency and severity scores for each domain. Higher scores indicate more behavioral disturbance
Conditions Studied
Interventions
- BEHAVIORAL Behavioral modification and education on pharmacologic treatments.
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-09 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
What the finished NCT03378245 record still lists
NCT03378245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 194-participant average among 11 other Dementia Alzheimers trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Dementia Alzheimers appearing as the primary indexed condition, and to 1 intervention - of which Behavioral modification and education on pharmacologic treatments. is the first listed.
NCT03378245 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT03378245 about?
NCT03378245 is a clinical study titled "Telemedicine-based, Multidisciplinary-team, Intervention to Reduce Unnecessary Hospitalizations". The purpose of this study is to investigate the use of telemedicine-based intervention at urban and rural skilled nursing facilities to recommend multidisciplinary dementia care to residents with dementia who are at risk for unnecessary hospitalization due behavioral or neuropsychiatric symptoms and...
What is the current status of trial NCT03378245?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2013-09. Estimated completion is 2020-07-31.
What conditions does trial NCT03378245 study?
This clinical trial studies the following conditions: Dementia Alzheimers, Disruptive Behavior.
What interventions are being tested in trial NCT03378245?
The interventions under investigation include: Behavioral modification and education on pharmacologic treatments. (BEHAVIORAL).
Who is sponsoring clinical trial NCT03378245?
This trial is sponsored by Richard Ronan Murphy, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03378245 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia Alzheimers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03378245's enrollment target sits among peer trials
16 12th of 11 the lowest of 11 other Dementia Alzheimers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia Alzheimers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multi-Center Study of Sensory Stimulation to Improve Brain Function
ACTIVE NOT RECRUITING · NA
-
A Spanish-language Caregiver-Enabled Care Program
ACTIVE NOT RECRUITING · NA
-
Optimizing Cognitive, Environmental, and Neuromotor Stimulation in Traumatic Brain Injury
COMPLETED · NA
-
Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers
COMPLETED · NA
-
Rural Dementia Caregiver Project
COMPLETED · NA
-
Assessing Cognitive Decline at Home
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia